{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T22:30:12Z","timestamp":1775341812485,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2505305"],"award-info":[{"award-number":["2022YFC2505305"]}]},{"name":"Renji Hospital Clinical Research Incubation Fund","award":["RJPY-DZX-004"],"award-info":[{"award-number":["RJPY-DZX-004"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473386"],"award-info":[{"award-number":["82473386"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Major Science and Technology Infrastructure for Translational Medicine (Shanghai) 2024 \u201cOpen Research Program\u201d Key Projects","award":["TMSK-2024-119"],"award-info":[{"award-number":["TMSK-2024-119"]}]},{"name":"Shanghai Municipal Education Commission's Artificial Intelligence-Powered Research Paradigm Reform and Discipline Advancement Program","award":["BJ1-9000-25-8010"],"award-info":[{"award-number":["BJ1-9000-25-8010"]}]},{"name":"Shanghai 2023 \u201cScience and Technology Innovation Action Plan\u201d Key Project on Computational Biology","award":["23JS1400803"],"award-info":[{"award-number":["23JS1400803"]}]},{"name":"Basic-Clinical Collaborative Innovation Project from Shanghai Immune Therapy Institute"},{"name":"Shanghai Science and Technology Commission Medical Innovation Clinical Research Special Project","award":["23Y21900400"],"award-info":[{"award-number":["23Y21900400"]}]},{"name":"Excellent Project of Shanghai Municipal Health Commission","award":["20244Z0004"],"award-info":[{"award-number":["20244Z0004"]}]},{"name":"Shanghai Key Program of Computational Biology","award":["23JS1400800"],"award-info":[{"award-number":["23JS1400800"]}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local Universities in Shanghai","doi-asserted-by":"crossref","award":["SHSMUZLCX20212601"],"award-info":[{"award-number":["SHSMUZLCX20212601"]}],"id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Simulation RCT Study of Shanghai Shenkang Three Year Action Plan","award":["Simulation RCT Study of Shanghai Shenkang Three Year Action Plan"],"award-info":[{"award-number":["Simulation RCT Study of Shanghai Shenkang Three Year Action Plan"]}]},{"name":"Shanghai Jiao Tong University Medical Engineering Interdisciplinary Research Fund - Key Project","award":["YG2024ZD07"],"award-info":[{"award-number":["YG2024ZD07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-02034-x","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:52:46Z","timestamp":1763416366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A multimodal AI model for precision prognosis in clear cell renal cell carcinoma: A multicenter study"],"prefix":"10.1038","volume":"8","author":[{"given":"Xinyi","family":"Zang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haolun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minggui","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiqiao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axide","family":"Haoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyu","family":"Zi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengfeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiran","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Ka-Wai","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy Yuen-Chun","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaozhao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangsheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2034_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA A Cancer J. Clin."},{"key":"2034_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch, H. et al. The 2022 world health organization classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours. Eur. Urol. 82, 458\u2013468 (2022).","journal-title":"Eur. Urol."},{"key":"2034_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.6004\/jnccn.2024.0008","volume":"22","author":"RJ Motzer","year":"2024","unstructured":"Motzer, R. J. et al. NCCN guidelines\u00ae insights: kidney cancer, version 2.2024: featured updates to the NCCN guidelines. J. Natl. Compr. Cancer Netw. 22, 4\u201316 (2024).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"2034_CR4","doi-asserted-by":"crossref","unstructured":"Haas D. N. B. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.387. 2016;","DOI":"10.1016\/S0140-6736(16)00559-6"},{"key":"2034_CR5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2106391","volume":"385","author":"TK Choueiri","year":"2021","unstructured":"Choueiri, T. K. et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. N. Engl. J. Med. 385, 683\u2013694 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2034_CR6","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa2312695","volume":"390","author":"TK Choueiri","year":"2024","unstructured":"Choueiri, T. K. et al. Overall survival with adjuvant pembrolizumab in renal-cell carcinoma. N. Engl. J. Med. 390, 1359\u20131371 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2034_CR7","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/cncr.11234","volume":"97","author":"BC Leibovich","year":"2003","unstructured":"Leibovich, B. C. et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97, 1663\u20131671 (2003).","journal-title":"Cancer"},{"key":"2034_CR8","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1200\/JCO.2002.05.111","volume":"20","author":"A Zisman","year":"2002","unstructured":"Zisman, A. et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. JCO 20, 4559\u20134566 (2002).","journal-title":"JCO"},{"key":"2034_CR9","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S1470-2045(15)70167-1","volume":"16","author":"B Rini","year":"2015","unstructured":"Rini, B. et al. A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies. Lancet Oncol. 16, 676\u2013685 (2015).","journal-title":"Lancet Oncol."},{"key":"2034_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1470-2045(18)30932-X","volume":"20","author":"JH Wei","year":"2019","unstructured":"Wei, J. H. et al. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study. Lancet Oncol. 20, 591\u2013600 (2019).","journal-title":"Lancet Oncol."},{"key":"2034_CR11","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1038\/s41591-023-02640-w","volume":"29","author":"K Cao","year":"2023","unstructured":"Cao, K. et al. Large-scale pancreatic cancer detection via non-contrast CT and deep learning. Nat. Med 29, 3033\u20133043 (2023).","journal-title":"Nat. Med"},{"key":"2034_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1136\/gutjnl-2019-319866","volume":"70","author":"K Sirinukunwattana","year":"2021","unstructured":"Sirinukunwattana, K. et al. Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning. Gut 70, 544\u2013554 (2021).","journal-title":"Gut"},{"key":"2034_CR13","doi-asserted-by":"publisher","unstructured":"Lee, Y. et al. Derivation of prognostic contextual histopathological features from whole-slide images of tumours via graph deep learning. Nat Biomed Eng. Published online August 18, https:\/\/doi.org\/10.1038\/s41551-022-00923-0.2022.","DOI":"10.1038\/s41551-022-00923-0"},{"key":"2034_CR14","doi-asserted-by":"publisher","first-page":"101848","DOI":"10.1016\/j.xcrm.2024.101848","volume":"5","author":"P Gao","year":"2024","unstructured":"Gao, P. et al. Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapy. Cell Rep. Med. 5, 101848 (2024).","journal-title":"Cell Rep. Med."},{"key":"2034_CR15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","volume":"3","author":"RS Vanguri","year":"2022","unstructured":"Vanguri, R. S. et al. Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer. Nat. Cancer 3, 1151\u20131164 (2022).","journal-title":"Nat. Cancer"},{"key":"2034_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s43018-022-00388-9","volume":"3","author":"KM Boehm","year":"2022","unstructured":"Boehm, K. M. et al. Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer. Nat. Cancer 3, 723\u2013733 (2022).","journal-title":"Nat. Cancer"},{"key":"2034_CR17","doi-asserted-by":"publisher","first-page":"102775","DOI":"10.1016\/j.eclinm.2024.102775","volume":"75","author":"P Zhu","year":"2024","unstructured":"Zhu, P., et al. Tumor contour irregularity on preoperative CT predicts prognosis in renal cell carcinoma: a multi-institutional study. eClinicalMedicine 75, 102775 (2024).","journal-title":"eClinicalMedicine"},{"key":"2034_CR18","doi-asserted-by":"crossref","unstructured":"Pallwein-Prettner, L. et al. Assessment and characterisation of common renal masses with CT and MRI. Published online 2011.","DOI":"10.1007\/s13244-011-0116-1"},{"key":"2034_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00345-018-2355-y","volume":"37","author":"C Lebacle","year":"2019","unstructured":"Lebacle, C. et al. Epidemiology, biology and treatment of sarcomatoid RCC: current state of the art. World J. Urol. 37, 115\u2013123 (2019).","journal-title":"World J. Urol."},{"key":"2034_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.urolonc.2017.12.012","volume":"36","author":"NE Mouallem","year":"2018","unstructured":"Mouallem, N. E., Smith, S. C. & Paul, A. K. Sarcomatoid renal cell carcinoma: biology and treatment advances. Urol. Oncol.: Semin. Original Investig. 36, 265\u2013271 (2018).","journal-title":"Urol. Oncol.: Semin. Original Investig."},{"key":"2034_CR21","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.eururo.2007.05.009","volume":"52","author":"Z Kirkali","year":"2007","unstructured":"Kirkali, Z. & Van Poppel, H. A critical analysis of surgery for kidney cancer with vena cava invasion. Eur. Urol. 52, 658\u2013662 (2007).","journal-title":"Eur. Urol."},{"key":"2034_CR22","doi-asserted-by":"publisher","unstructured":"Khene, Z. E. et al. Application of Machine Learning Models to Predict Recurrence After Surgical Resection of Nonmetastatic Renal Cell Carcinoma. European Urology Oncology. Published online August 2022: S2588931122001377. https:\/\/doi.org\/10.1016\/j.euo.2022.07.007.","DOI":"10.1016\/j.euo.2022.07.007"},{"key":"2034_CR23","doi-asserted-by":"crossref","unstructured":"Nie, P. A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study. European Radiology. Published online 2023.","DOI":"10.1007\/s00330-023-09869-6"},{"key":"2034_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41416-021-01640-2","volume":"126","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma. Br. J. Cancer 126, 771\u2013777 (2022).","journal-title":"Br. J. Cancer"},{"key":"2034_CR25","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1016\/S2589-7500(23)00095-X","volume":"5","author":"CP Gui","year":"2023","unstructured":"Gui, C. P. et al. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study. Lancet Digit. Health 5, e515\u2013e524 (2023).","journal-title":"Lancet Digit. Health"},{"key":"2034_CR26","doi-asserted-by":"publisher","unstructured":"Chen, S. et al. Deep learning-based multimodel prediction for disease-free survival status of patients with clear cell renal cell carcinoma after surgery: a multicenter cohort study. International Journal of Surgery. Published online March 4, 2024. https:\/\/doi.org\/10.1097\/JS9.0000000000001222.","DOI":"10.1097\/JS9.0000000000001222"},{"key":"2034_CR27","doi-asserted-by":"crossref","unstructured":"Vorontsov, E. et al. A foundation model for clinical-grade computational pathology and rare cancers detection. Nat. Med. 30, 2924\u20132935 (2024).","DOI":"10.1038\/s41591-024-03141-0"},{"key":"2034_CR28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41586-024-08378-w","volume":"638","author":"J Xiang","year":"2025","unstructured":"Xiang, J. et al. A vision-language foundation model for precision oncology. Nature 638, 769\u2013778 (2025).","journal-title":"Nature"},{"key":"2034_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/s41591-024-02857-3","volume":"30","author":"RJ Chen","year":"2024","unstructured":"Chen, R. J. et al. Towards a general-purpose foundation model for computational pathology. Nat. Med. 30, 850\u2013862 (2024).","journal-title":"Nat. Med."},{"key":"2034_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.eururo.2010.10.001","volume":"59","author":"JI Mart\u00ednez-Salamanca","year":"2011","unstructured":"Mart\u00ednez-Salamanca, J. I. et al. Prognostic impact of the 2009 UICC\/AJCC TNM staging system for renal cell carcinoma with venous extension. Eur. Urol. 59, 120\u2013127 (2011).","journal-title":"Eur. Urol."},{"key":"2034_CR31","doi-asserted-by":"crossref","unstructured":"Amin, M. B. et al. The Eighth Edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA CANCER J CLIN. 67.2017;","DOI":"10.3322\/caac.21388"},{"key":"2034_CR32","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1200\/JCO.19.00107","volume":"37","author":"AF Correa","year":"2019","unstructured":"Correa, A. F. et al. Predicting renal cancer recurrence: defining limitations of existing prognostic models with prospective trial-based validation. JCO 37, 2062\u20132071 (2019).","journal-title":"JCO"},{"key":"2034_CR33","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.eururo.2021.10.033","volume":"81","author":"ZE Khene","year":"2022","unstructured":"Khene, Z. E., Bex, A. & Bensalah, K. Adjuvant therapy after surgical resection of nonmetastatic renal cell carcinoma: one size does not fit all. Eur. Urol. 81, 432\u2013433 (2022).","journal-title":"Eur. Urol."},{"key":"2034_CR34","doi-asserted-by":"publisher","unstructured":"Naito, H. et al. Postoperative recurrence factors in patients with pT3N0M0 clear cell renal cell carcinoma, called M0 intermediate-high-risk group of the KEYNOTE 564 trial. Preprint at https:\/\/doi.org\/10.21203\/rs.3.rs-2905509\/v1 (2023).","DOI":"10.21203\/rs.3.rs-2905509\/v1"},{"key":"2034_CR35","doi-asserted-by":"crossref","unstructured":"Liu, Z. et al. Re: Overall Survival with Adjuvant Pembrolizumab in Renal-cell Carcinoma. Eur. Urol. 86, 482\u2013483 (2024).","DOI":"10.1016\/j.eururo.2024.06.014"},{"key":"2034_CR36","doi-asserted-by":"crossref","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. M. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 350, g7594 (2015).","DOI":"10.1136\/bmj.g7594"},{"key":"2034_CR37","doi-asserted-by":"crossref","unstructured":"Altman, D. G., McShane, L. M., Sauerbrei, W. & Taube, S. E. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. BMC Med. 10, 51 (2012).","DOI":"10.1186\/1741-7015-10-51"},{"key":"2034_CR38","doi-asserted-by":"crossref","unstructured":"Otsu, N. Threshold Selection Method From Gray-level Histograms. IEEE Trans. Syst. Man Cybern. 9, 62\u201366 (1979).","DOI":"10.1109\/TSMC.1979.4310076"},{"key":"2034_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0482-1","volume":"18","author":"JL Katzman","year":"2018","unstructured":"Katzman, J. L. et al. DeepSurv: personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med. Res. Methodol. 18, 24 (2018).","journal-title":"BMC Med. Res. Methodol."},{"key":"2034_CR40","unstructured":"Selvaraju, R. R. et al. In Proceedings of the IEEE international conference on computer vision. 618\u2013626."},{"key":"2034_CR41","unstructured":"Ilse, M., Tomczak, J. & Welling, M. In International conference on machine learning. 2127\u20132136 (PMLR)."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02034-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02034-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:52:50Z","timestamp":1763416370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-02034-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2034"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-02034-x","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"668"}}